Suppr超能文献

通畅胶囊的症状性滞留:一项多中心真实病例系列研究

Symptomatic retention of the patency capsule: a multicenter real life case series.

作者信息

Kopylov Uri, Nemeth Artur, Cebrian Alba, Wurm Johansson Gabriele, Thorlacius Henrik, Fernandez-Urien Sainz Ignacio, Koulaouzidis Anastasios, Eliakim Rami, Toth Ervin

机构信息

Department of Gastroenterology, Chaim Sheba Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Department of Gastroenterology, Skåne University Hospital, Malmö, Lund University, Sweden.

出版信息

Endosc Int Open. 2016 Sep;4(9):E964-9. doi: 10.1055/s-0042-112588. Epub 2016 Aug 8.

Abstract

BACKGROUND AND AIMS

The patency capsule is designed to evaluate the patency of the small bowel before administration of small-bowel capsule endoscopy (SBCE) in patients at high risk of retention. The utilization of a patency capsule may be associated with a risk of symptomatic retention, but very few cases have been reported to date. The aim of our study was to describe our experience with this rare complication of a patency capsule.

METHODS

This was a multicenter retrospective case series. The medical records of patients who underwent a patency capsule test were scanned and all cases of symptomatic retention were collected.

RESULTS

In total, 20 symptomatic cases of retention out of 1615 (1.2 %) patency capsule tests were identified; in one patient, the patency capsule was retained in the esophagus, in the rest, the capsule was detected in the small bowel resulting in abdominal pain or small-bowel obstruction. One patient (5 %) required surgery; all other patients resolved spontaneously or after corticosteroid therapy.

CONCLUSIONS

Symptomatic patency capsule retention is a very rare complication with a favorable prognosis. It should be recognized but its use in patients with suspected small-bowel stenosis should not be discouraged.

摘要

背景与目的

通畅性胶囊旨在评估小肠胶囊内镜检查(SBCE)在高滞留风险患者中给药前小肠的通畅情况。使用通畅性胶囊可能会有症状性滞留的风险,但迄今为止报道的病例极少。我们研究的目的是描述我们对这种通畅性胶囊罕见并发症的经验。

方法

这是一项多中心回顾性病例系列研究。对接受通畅性胶囊测试的患者的病历进行扫描,并收集所有症状性滞留病例。

结果

在1615次通畅性胶囊测试中,共发现20例(1.2%)症状性滞留病例;1例患者中,通畅性胶囊滞留在食管,其余病例中,胶囊在小肠被检测到,导致腹痛或小肠梗阻。1例患者(5%)需要手术治疗;所有其他患者自行缓解或经皮质类固醇治疗后缓解。

结论

症状性通畅性胶囊滞留是一种非常罕见的并发症,预后良好。应认识到这一点,但对于疑似小肠狭窄的患者,不应阻碍使用通畅性胶囊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b416/5025315/52cfbf8ec0f9/10-1055-s-0042-112588-i606ei1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验